Kennametal Innovation Recognized as Edison Award Finalist
Get Alerts KMT Hot Sheet
Join SI Premium – FREE
The innovative tool mimics organic shape adaptations observed in nature. The result is a tool that is 45% lighter and has demonstrated a reduced machining time by approximately 50% compared to a conventional solution for the targeted customer. The technology is poised to enhance productivity and efficiency for customers, particularly in the precision machining of components for transportation applications.
"At Kennametal, we push the boundaries of innovation in our industries and being recognized as an Edison Award finalist for our KENionic™ technology is a testament to that dedication," said Dr.
Award winners will be announced on
About Kennametal
With over 80 years as an industrial technology leader, Kennametal Inc. delivers productivity to customers through materials science, tooling and wear-resistant solutions. Customers across aerospace and defense, earthworks, energy, general engineering and transportation turn to Kennametal to help them manufacture with precision and efficiency. Every day approximately 8,700 employees are helping customers in nearly 100 countries stay competitive. Kennametal generated $2.1 billion in revenues in fiscal 2023. Learn more at www.kennametal.com. Follow @Kennametal: Instagram, Facebook, LinkedIn and YouTube.
About the Edison Awards
Established in 1987, The Edison Awards™ is among the most prestigious accolades honoring excellence in new product and service development, marketing, design and innovation. Their mission is to be a leader in globally recognizing, honoring and fostering innovation and innovators to create a positive impact in the world.
View original content to download multimedia:https://www.prnewswire.com/news-releases/kennametal-innovation-recognized-as-edison-award-finalist-302057639.html
SOURCE Kennametal Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI-empowered Pipeline-in-a-drug Option: Insilico Medicine Nominates ISM9077, Potential First-in-class Target Y Inhibitor, as Preclinical Candidate (PCC) for Ocular Diseases, Inflammatory Disorders and
- Ecopetrol Announces Successful Auction Result for the Acquisition of Approximately 25% of the Share Capital of Brava Energia S.A.
- Greenberg Traurig Represents The Ardent Companies in Strategic Recapitalization of Self-Storage Portfolio with StepStone Group
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share